Vanda Pharmaceuticals | VNDA - Market Capitalization


Vanda Pharmaceuticals reported $307.3M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Veracyte USD 4.69B 2.12B Jun/2026